Medtech Funding Insights

Sam discusses the capital intensity of Medtech versus software companies, emphasizing the need for Medtech to keep budgets low initially. He highlights the challenges Medtech companies face, such as underestimating the healthcare sales cycle and the time required for adoption beyond FDA approval.